amcenestrant,sar439859
sanofi
['ameera-3', 'amcenestrant', 'medsir']
(1/2) great talk by sharing data of ameera-3 trial which did not meet its primary objective; pfs was numerically similar between amcenestrant and treatment of physician s choice (median 3.6 vs 3.7 months; hr1.05) in pts with endocrine-resistant er+/her2 abc. #esmo22 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM